Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1480293
European Journal of Endocrinology, Vol 148, Issue 3, 293-300
Copyright © 2003 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diez, J.
Right arrow Articles by Iglesias, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diez, J.
Right arrow Articles by Iglesias, P

Articles

The role of the novel adipocyte-derived hormone adiponectin in human disease

JJ Diez and P Iglesias

Department of Endocrinology, Hospital Ramon y Cajal, Madrid, Spain. mibarsd@infomed.es

Adiponectin, also called GBP-28, apM1, AdipoQ and Acrp30, is a novel adipose tIssue-specific protein that has structural homology to collagen VIII and X and complement factor C1q, and that circulates in human plasma at high levels. It is one of the physiologically active polypeptides secreted by adipose tIssue, whose multiple functions have started to be understood in the last few Years.A reduction in adiponectin expression is associated with insulin resistance in some animal models. Administration of adiponectin has been accompanied by a reduction in plasma glucose and an increase in insulin sensitivity. In addition, thiazolidinediones, drugs that enhance insulin sensitivity through stimulation of the peroxisome proliferator-activated receptor-gamma, increase plasma adiponectin and mRNA levels in mice. On the other hand, this adipocyte protein seems to play a protective role in experimental models of vascular injury. In humans, adiponectin levels are inversely related to the degree of adiposity and positively associated with insulin sensitivity both in healthy subjects and in diabetic patients. Plasma adiponectin levels have been reported to be decreased in some insulin-resistant states, such as obesity and type 2 diabetes mellitus, and also in patients with coronary artery disease. On the contrary, chronic renal failure, type 1 diabetes and anorexia nervosa are associated with increased plasma adiponectin levels. Concentrations of plasma adiponectin have been shown to correlate negatively with glucose, insulin, triglyceride levels and body mass index, and positively with high-density lipoprotein-cholesterol levels and insulin-stimulated glucose disposal. Weight loss and therapy with thiazolidinediones increased endogenous adiponectin production in humans.Adiponectin increases insulin sensitivity by increasing tIssue fat oxidation, resulting in reduced circulating fatty acid levels and reduced intracellular triglyceride contents in liver and muscle. This protein also suppresses the expression of adhesion molecules in vascular endothelial cells and cytokine production from macrophages, thus inhibiting the inflammatory processes that occur during the early phases of atherosclerosis. In view of these data, it is possible that hypoadiponectinemia may play a role in the development of atherosclerotic vascular disease.In summary, the ability of adiponectin to increase insulin sensitivity in conjunction with its anti-inflammatory and anti-atherogenic properties have made this novel adipocytokine a promising therapeutic tool for the future, with potential applications in states associated with low plasma adiponectin levels.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
T. Sir-Petermann, L. Marquez, M. Carcamo, C. Hitschfeld, E. Codner, M. Maliqueo, B. Echiburu, P. Aranda, N. Crisosto, and F. Cassorla
Effects of Birth Weight on Anti-Mullerian Hormone Serum Concentrations in Infant Girls
J. Clin. Endocrinol. Metab., February 1, 2010; 95(2): 903 - 910.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
C. Krisanapun, S.-H. Lee, P. Peungvicha, R. Temsiririrkkul, and S. J. Baek
Antidiabetic Activities of Abutilon indicum (L.) Sweet are Mediated by Enhancement of Adipocyte Differentiation and Activation of the GLUT1 Promoter
Evid. Based Complement. Altern. Med., January 28, 2010; (2010): neq004v1 - neq004.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
D. K. Kim, H. S. Lillehoj, S. H. Lee, S. I. Jang, and D. Bravo
High-throughput gene expression analysis of intestinal intraepithelial lymphocytes after oral feeding of carvacrol, cinnamaldehyde, or Capsicum oleoresin
Poult. Sci., January 1, 2010; 89(1): 68 - 81.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D. A. Van Vugt
Brain imaging studies of appetite in the context of obesity and the menstrual cycle
Hum. Reprod. Update, November 19, 2009; (2009) dmp051v1.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Sucunza, M. J. Barahona, E. Resmini, J.-M. Fernandez-Real, W. Ricart, J. Farrerons, J. Rodriguez Espinosa, A.-M. Marin, T. Puig, and S. M. Webb
A Link between Bone Mineral Density and Serum Adiponectin and Visfatin Levels in Acromegaly
J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3889 - 3896.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Cassidy, P. Skidmore, E. B. Rimm, A. Welch, S. Fairweather-Tait, J. Skinner, K. Burling, J. B. Richards, T. D. Spector, and A. J. MacGregor
Plasma Adiponectin Concentrations Are Associated with Body Composition and Plant-Based Dietary Factors in Female Twins
J. Nutr., February 1, 2009; 139(2): 353 - 358.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. W. Sull, H. J. Kim, J. E. Yun, G. Kim, E. J. Park, S. Kim, H. Y. Lee, and S. H. Jee
Serum adiponectin is associated with family history of diabetes independently of obesity and insulin resistance in healthy Korean men and women
Eur. J. Endocrinol., January 1, 2009; 160(1): 39 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Leth, K. K. Andersen, J. Frystyk, L. Tarnow, P. Rossing, H.-H. Parving, and A. Flyvbjerg
Elevated Levels of High-Molecular-Weight Adiponectin in Type 1 Diabetes
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3186 - 3191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. E. Wert
Does adiponectin play a role in pulmonary emphysema?
Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1032 - L1034.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. Kyriakakou, A. Malamitsi-Puchner, H. Militsi, T. Boutsikou, A. Margeli, D. Hassiakos, C. Kanaka-Gantenbein, I. Papassotiriou, and G. Mastorakos
Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers
Eur. J. Endocrinol., March 1, 2008; 158(3): 343 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Sir-Petermann, M. Maliqueo, E. Codner, B. Echiburu, N. Crisosto, V. Perez, F. Perez-Bravo, and F. Cassorla
Early Metabolic Derangements in Daughters of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4637 - 4642.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Saito, D. Fujioka, K.-i. Kawabata, T. Kobayashi, T. Yano, T. Nakamura, Y. Kodama, H. Takano, Y. Kitta, J.-e. Obata, et al.
Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-{alpha}-treated cardiomyocytes in association with improved glucose uptake
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3490 - H3497.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Archanco, J. Gomez-Ambrosi, M. Tena-Sempere, G. Fruhbeck, and M. A. Burrell
Expression of Leptin and Adiponectin in the Rat Oviduct
J. Histochem. Cytochem., October 1, 2007; 55(10): 1027 - 1037.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. M. Maahs, L. G. Ogden, J. K. Snell-Bergeon, G. L. Kinney, R. P. Wadwa, J. E. Hokanson, D. Dabelea, A. Kretowski, R. H. Eckel, and M. Rewers
Determinants of Serum Adiponectin in Persons with and without Type 1 Diabetes
Am. J. Epidemiol., September 15, 2007; 166(6): 731 - 740.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 858S - 866S.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Sir-Petermann, B. Echiburu, M M. Maliqueo, N. Crisosto, F. Sanchez, C. Hitschfeld, M. Carcamo, P. Amigo, and F. Perez-Bravo
Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome
Hum. Reprod., July 1, 2007; 22(7): 1830 - 1836.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Jurimae and T. Jurimae
Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E42 - E47.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. Qatanani and M. A. Lazar
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Genes & Dev., June 15, 2007; 21(12): 1443 - 1455.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. Santosa, I. Demonty, A. H. Lichtenstein, K. Cianflone, and P. J.H. Jones
An Investigation of Hormone and Lipid Associations after Weight Loss in Women
J. Am. Coll. Nutr., June 1, 2007; 26(3): 250 - 258.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. Y. Bang, J. L. Saver, B. Ovbiagele, Y. J. Choi, S. R. Yoon, and K. H. Lee
Adiponectin levels in patients with intracranial atherosclerosis
Neurology, May 29, 2007; 68(22): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
I. M. Wahba and R. H. Mak
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 550 - 562.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Friberg, C. S. Mantzoros, and A. Wolk
Diabetes and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study
Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 276 - 280.
[Abstract] [Full Text] [PDF]


Home page
Exp Biol MedHome page
R. R. Kraemer and V. D. Castracane
Exercise and Humoral Mediators of Peripheral Energy Balance: Ghrelin and Adiponectin
Exp Biol Med, February 1, 2007; 232(2): 184 - 194.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Liu, M. D. Michael, S. Kash, W. R. Bensch, B. P. Monia, S. F. Murray, K. A. Otto, S. K. Syed, S. Bhanot, K. W. Sloop, et al.
Deficiency of Adiponectin Receptor 2 Reduces Diet-Induced Insulin Resistance but Promotes Type 2 Diabetes
Endocrinology, February 1, 2007; 148(2): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. D. Yee, N. Williams, P. Wen, D. C. Young, J. Lester, M. V. Johnson, W. B. Farrar, M. J. Walker, S. P. Povoski, S. Suster, et al.
Pilot Study of Rosiglitazone Therapy in Women with Breast Cancer: Effects of Short-term Therapy on Tumor Tissue and Serum Markers
Clin. Cancer Res., January 1, 2007; 13(1): 246 - 252.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Friberg, C. S. Mantzoros, and A. Wolk
Physical Activity and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2136 - 2140.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Ategbo, O. Grissa, A. Yessoufou, A. Hichami, K. L. Dramane, K. Moutairou, A. Miled, A. Grissa, M. Jerbi, Z. Tabka, et al.
Modulation of Adipokines and Cytokines in Gestational Diabetes and Macrosomia
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4137 - 4143.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
D. Glintborg, M. Andersen, C. Hagen, J. Frystyk, V. Hulstrom, A. Flyvbjerg, and A. P. Hermann
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
Eur. J. Endocrinol., August 1, 2006; 155(2): 337 - 345.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler
Role of Adipose Tissue as an Inflammatory Organ in Human Diseases
Endocr. Rev., August 1, 2006; 27(5): 449 - 467.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Bojesen, K. Kristensen, N. H. Birkebaek, J. Fedder, L. Mosekilde, P. Bennett, P. Laurberg, J. Frystyk, A. Flyvbjerg, J. S. Christiansen, et al.
The Metabolic Syndrome Is Frequent in Klinefelter's Syndrome and Is Associated With Abdominal Obesity and Hypogonadism
Diabetes Care, July 1, 2006; 29(7): 1591 - 1598.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Fujioka, K.-i. Kawabata, Y. Saito, T. Kobayashi, T. Nakamura, Y. Kodama, H. Takano, J.-e. Obata, Y. Kitta, K. Umetani, et al.
Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2409 - H2416.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. B. Kim, M. Kong, T. M. Kim, Y. H. Suh, W.-H. Kim, J. H. Lim, J. H. Song, and M. H. Jung
NFATc4 and ATF3 Negatively Regulate Adiponectin Gene Expression in 3T3-L1 Adipocytes.
Diabetes, May 1, 2006; 55(5): 1342 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. Englund Ogge, G. Brohall, C. J. Behre, C. Schmidt, and B. Fagerberg
Alcohol Consumption in Relation to Metabolic Regulation, Inflammation, and Adiponectin in 64-Year-Old Caucasian Women: A population-based study with a focus on impaired glucose regulation
Diabetes Care, April 1, 2006; 29(4): 908 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ehling, A. Schaffler, H. Herfarth, I. H. Tarner, S. Anders, O. Distler, G. Paul, J. Distler, S. Gay, J. Scholmerich, et al.
The Potential of Adiponectin in Driving Arthritis
J. Immunol., April 1, 2006; 176(7): 4468 - 4478.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Pagano, G. Soardo, C. Pilon, C. Milocco, L. Basan, G. Milan, D. Donnini, D. Faggian, M. Mussap, M. Plebani, et al.
Increased Serum Resistin in Nonalcoholic Fatty Liver Disease Is Related to Liver Disease Severity and Not to Insulin Resistance
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1081 - 1086.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Qiao, J. Schaack, and J. Shao
Suppression of Adiponectin Gene Expression by Histone Deacetylase Inhibitor Valproic Acid
Endocrinology, February 1, 2006; 147(2): 865 - 874.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. Knobler, M. Benderly, V. Boyko, S. Behar, Z. Matas, A. Rubinstein, I. Raz, and J. Wainstein
Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose
Eur. J. Endocrinol., January 1, 2006; 154(1): 87 - 92.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Greco, G. Latini, F. Chiarelli, P. Iannetti, and A. Verrotti
Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid
Neurology, December 13, 2005; 65(11): 1808 - 1809.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
X Fang, R Palanivel, X Zhou, Y Liu, A Xu, Y Wang, and G Sweeney
Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts
J. Mol. Endocrinol., December 1, 2005; 35(3): 465 - 476.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Zitzmann, M. Erren, A. Kamischke, M. Simoni, and E. Nieschlag
Endogenous Progesterone and the Exogenous Progestin Norethisterone Enanthate Are Associated with a Proinflammatory Profile in Healthy Men
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6603 - 6608.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. K. Wei, E. Giovannucci, C. S. Fuchs, W. C. Willett, and C. S. Mantzoros
Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study
J Natl Cancer Inst, November 16, 2005; 97(22): 1688 - 1694.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. G. Fatouros, S. Tournis, D. Leontsini, A. Z. Jamurtas, M. Sxina, P. Thomakos, M. Manousaki, I. Douroudos, K. Taxildaris, and A. Mitrakou
Leptin and Adiponectin Responses in Overweight Inactive Elderly following Resistance Training and Detraining Are Intensity Related
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5970 - 5977.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Bobbert, H. Rochlitz, U. Wegewitz, S. Akpulat, K. Mai, M. O. Weickert, M. Mohlig, A. F.H. Pfeiffer, and J. Spranger
Changes of Adiponectin Oligomer Composition by Moderate Weight Reduction
Diabetes, September 1, 2005; 54(9): 2712 - 2719.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. P. Efstathiou, D. I. Tsioulos, A. G. Tsiakou, Y. E. Gratsias, A. V. Pefanis, and T. D. Mountokalakis
Plasma Adiponectin Levels and Five-Year Survival After First-Ever Ischemic Stroke
Stroke, September 1, 2005; 36(9): 1915 - 1919.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
D. Hamerman
Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies
QJM, July 1, 2005; 98(7): 467 - 484.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Pagano, O. Marin, A. Calcagno, P. Schiappelli, C. Pilon, G. Milan, M. Bertelli, E. Fanin, G. Andrighetto, G. Federspil, et al.
Increased Serum Resistin in Adults with Prader-Willi Syndrome Is Related to Obesity and Not to Insulin Resistance
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4335 - 4340.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Schaffler and H Herfarth
Creeping fat in Crohn's disease: travelling in a creeper lane of research?
Gut, June 1, 2005; 54(6): 742 - 744.
[Full Text] [PDF]


Home page
DiabetesHome page
L. Qiao, P. S. MacLean, J. Schaack, D. J. Orlicky, C. Darimont, M. Pagliassotti, J. E. Friedman, and J. Shao
C/EBP{alpha} Regulates Human Adiponectin Gene Transcription Through an Intronic Enhancer
Diabetes, June 1, 2005; 54(6): 1744 - 1754.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Satoh, M.T. A. Nguyen, M. Trujillo, T. Imamura, I. Usui, P. E. Scherer, and J. M. Olefsky
Adenovirus-Mediated Adiponectin Expression Augments Skeletal Muscle Insulin Sensitivity in Male Wistar Rats
Diabetes, May 1, 2005; 54(5): 1304 - 1313.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Tanko, Y. Z. Bagger, G. Qin, P. Alexandersen, P. J. Larsen, and C. Christiansen
Enlarged Waist Combined With Elevated Triglycerides Is a Strong Predictor of Accelerated Atherogenesis and Related Cardiovascular Mortality in Postmenopausal Women
Circulation, April 19, 2005; 111(15): 1883 - 1890.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Maahs, L. G. Ogden, G. L. Kinney, P. Wadwa, J. K. Snell-Bergeon, D. Dabelea, J. E. Hokanson, J. Ehrlich, R. H. Eckel, and M. Rewers
Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification
Circulation, February 15, 2005; 111(6): 747 - 753.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A M Diehl, Z P Li, H Z Lin, and S Q Yang
Cytokines and the pathogenesis of non-alcoholic steatohepatitis
Gut, February 1, 2005; 54(2): 303 - 306.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Ishikawa, J. Kitayama, S. Kazama, T. Hiramatsu, K. Hatano, and H. Nagawa
Plasma Adiponectin and Gastric Cancer
Clin. Cancer Res., January 15, 2005; 11(2): 466 - 472.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
T. J Wilkin and L. D Voss
Metabolic syndrome: maladaptation to a modern world
J R Soc Med, November 1, 2004; 97(11): 511 - 520.
[Full Text] [PDF]


Home page
EndocrinologyHome page
N. Ueno, M. G. Dube, A. Inui, P. S. Kalra, and S. P. Kalra
Leptin Modulates Orexigenic Effects of Ghrelin and Attenuates Adiponectin and Insulin Levels and Selectively the Dark-Phase Feeding as Revealed by Central Leptin Gene Therapy
Endocrinology, September 1, 2004; 145(9): 4176 - 4184.
[Abstract] [Full Text] [PDF]


Home page
J Gerontol A Biol Sci Med SciHome page
E. Zoico, V. Di Francesco, G. Mazzali, R. Vettor, F. Fantin, L. Bissoli, S. Guariento, O. Bosello, and M. Zamboni
Adipocytokines, Fat Distribution, and Insulin Resistance in Elderly Men and Women
J Gerontol A Biol Sci Med Sci, September 1, 2004; 59(9): M935 - M939.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Reinehr, C. Roth, T. Menke, and W. Andler
Adiponectin before and after Weight Loss in Obese Children
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3790 - 3794.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Panidis, A. Kourtis, A. Kukuvitis, D. Farmakiotis, N. Xita, I. Georgiou, and A. Tsatsoulis
Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of {Delta}4-androstenedione
Hum. Reprod., August 1, 2004; 19(8): 1728 - 1733.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
U. J. F. Tietge, K. H. W. Boker, M. P. Manns, and M. J. Bahr
Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E82 - E89.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. E. Kershaw and J. S. Flier
Adipose Tissue as an Endocrine Organ
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2548 - 2556.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. M. Gale, V. D. Castracane, and C. S. Mantzoros
Energy Homeostasis, Obesity and Eating Disorders: Recent Advances in Endocrinology
J. Nutr., February 1, 2004; 134(2): 295 - 298.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. J.G. Hanley, P. W. Connelly, S. B. Harris, and B. Zinman
Adiponectin in a Native Canadian Population Experiencing Rapid Epidemiological Transition
Diabetes Care, December 1, 2003; 26(12): 3219 - 3225.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M. J. Quon
Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells
J. Biol. Chem., November 7, 2003; 278(45): 45021 - 45026.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. S. Lihn, B. Richelsen, S. B. Pedersen, S. B. Haugaard, G. S. Rathje, S. Madsbad, and O. Andersen
Increased expression of TNF-{alpha}, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels
Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1072 - E1080.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. E. Ramsay, N. Jamieson, I. A. Greer, and N. Sattar
Paradoxical Elevation in Adiponectin Concentrations in Women With Preeclampsia
Hypertension, November 1, 2003; 42(5): 891 - 894.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 European Society of Endocrinology.